Zura Bio Ltd (ZURA)

Apr 03, 2025

H.C. Wainwright cuts Zura Bio stock target to $3, keeps neutral rating - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

ZURA stock touches 52-week low at $1.07 amid market challenges - Investing.com

Apr 03, 2025

Apr 02, 2025

Insiders' US$1.01m Investments In Red Following Zura Bio's US$21m Dip In Market Value - simplywall.st

Apr 02, 2025

Mar 29, 2025

Cantor Fitzgerald Forecasts Weaker Earnings for Zura Bio - Defense World

Mar 29, 2025

Mar 27, 2025

Zura Bio (NASDAQ:ZURA) Price Target Lowered to $10.00 at Chardan Capital - Defense World

Mar 27, 2025

Mar 27, 2025

Zura Bio Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Mar 26, 2025

Chardan cuts Zura Bio stock target to $10, keeps buy rating By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Chardan cuts Zura Bio stock target to $10, keeps buy rating - Investing.com Australia

Mar 26, 2025

Mar 25, 2025

Guggenheim maintains Zura Bio stock buy rating, $15 target By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Guggenheim maintains Zura Bio stock buy rating, $15 target - Investing.com

Mar 25, 2025

Mar 25, 2025

Leerink maintains $12 target on Zura Bio stock post-earnings By Investing.com - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Leerink maintains $12 target on Zura Bio stock post-earnings - Investing.com

Mar 25, 2025

Mar 25, 2025

Zura Bio Ltd expected to post a loss of 16 cents a shareEarnings Preview - TradingView

Mar 25, 2025

Mar 25, 2025

Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates - Yahoo Finance

Mar 25, 2025

Mar 20, 2025

Zura Bio (ZURA) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 13, 2025

Zura Bio Limited (NASDAQ:ZURA) Receives $15.80 Consensus Price Target from Analysts - Defense World

Mar 13, 2025

Mar 11, 2025

Rhumbline Advisers Has $94,000 Stock Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World

Mar 11, 2025

Feb 24, 2025

Zura Bio to Present at the Leerink Partners Global Healthcare Conference - Yahoo Finance

Feb 24, 2025

Feb 24, 2025

Can Zura Bio's Novel Dual-Pathway Antibodies Transform Autoimmune Treatment? Key Updates Coming - Stock Titan

Feb 24, 2025

Feb 16, 2025

Analysts Set Zura Bio Limited (NASDAQ:ZURA) Price Target at $15.80 - Defense World

Feb 16, 2025

Feb 14, 2025

Zura Bio Limited (NASDAQ:ZURA) Shares Purchased by SG Americas Securities LLC - Defense World

Feb 14, 2025

Feb 13, 2025

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - ADVFN

Feb 13, 2025

Feb 12, 2025

ZURA stock touches 52-week low at $1.44 amid market shifts - Investing.com Nigeria

Feb 12, 2025

Feb 11, 2025

ZURA stock touches 52-week low at $1.44 amid market shifts By Investing.com - Investing.com South Africa

Feb 11, 2025

Feb 03, 2025

After losing 43% in the past year, Zura Bio Limited (NASDAQ:ZURA) institutional owners must be relieved by the recent gain - Simply Wall St

Feb 03, 2025

Jan 26, 2025

Zura Bio (NASDAQ:ZURA) vs. Aptose Biosciences (NASDAQ:APTO) Critical Contrast - Defense World

Jan 26, 2025

Jan 25, 2025

Down -35.58% in 4 Weeks, Here's Why You Should You Buy the Dip in Zura Bio Limited (ZURA) - MSN

Jan 25, 2025

Jan 23, 2025

Cantor Fitzgerald Predicts Zura Bio FY2025 Earnings - MarketBeat

Jan 23, 2025

Jan 22, 2025

We Think Zura Bio (NASDAQ:ZURA) Can Afford To Drive Business Growth - Yahoo Finance

Jan 22, 2025

Jan 21, 2025

Barclays PLC Purchases 56,757 Shares of Zura Bio Limited (NASDAQ:ZURA) - Defense World

Jan 21, 2025

Jan 13, 2025

ZURA stock touches 52-week low at $1.97 amid market shifts - Investing.com Canada

Jan 13, 2025

Jan 13, 2025

Corporate Overview January 2025 Advancing Dual Pathway Biologic Candidates: Addressing Unmet Needs in Autoimmune and Inflammatory Diseases - Marketscreener.com

Jan 13, 2025

Jan 13, 2025

Zura Bio Highlights Strategic Goals and Clinical Advances - TipRanks

Jan 13, 2025

Jan 06, 2025

Barclays PLC Raises Stock Holdings in Zura Bio Limited (NASDAQ:ZURA) - Defense World

Jan 06, 2025

Jan 02, 2025

State Street Corp Increases Position in Zura Bio Limited (NASDAQ:ZURA) - Defense World

Jan 02, 2025

Dec 27, 2024

Reversal Of Fortune For Zura Bio Insiders Who Made A US$1.01m Purchase - Simply Wall St

Dec 27, 2024

Dec 25, 2024

Zura Bio’s (ZURA) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Dec 25, 2024

Dec 24, 2024

Zura Bio shares outlook positive as Phase 2 TibuSURE study evaluates key SSc complications - Investing.com India

Dec 24, 2024

Dec 24, 2024

Zura Bio begins Phase 2 study for systemic sclerosis treatment By Investing.com - Investing.com South Africa

Dec 24, 2024

Dec 24, 2024

Zura Bio initiates Phase II systemic sclerosis treatment trial - Yahoo Finance

Dec 24, 2024

Dec 23, 2024

Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis - Quantisnow

Dec 23, 2024

Dec 18, 2024

17,442 Shares in Zura Bio Limited (NASDAQ:ZURA) Acquired by The Manufacturers Life Insurance Company - Defense World

Dec 18, 2024

Dec 14, 2024

Zura Bio FY2025 EPS Forecast Increased by Leerink Partnrs - Defense World

Dec 14, 2024

Dec 13, 2024

Zura Bio FY2025 EPS Forecast Boosted by Leerink Partnrs - MarketBeat

Dec 13, 2024